9th Circ. Lets Ex-CytoDyn CEO Keep $6.2M In Stock Profits
The Ninth Circuit on Friday upheld a Washington federal court's dismissal of a suit filed by CytoDyn shareholders seeking to force the former CEO to disgorge more than $6.2 million he...To view the full article, register now.
Already a subscriber? Click here to view full article